Although the National Growth Fund has been wound down following its third round of funding, several millions are still available for promising projects, including in the life sciences. Biotech Booster, RegMed XB and Oncode Accelerator remain hard at work scouting for the right projects.
Nettie Buitelaar, CEO at Biotech Booster says: “To put it simply: don’t miss out on this opportunity. This is your chance to take a major step forward, so that investors start paying attention to your idea.”
Read the article in the Brightlands Maastricht Health Campus Glossy, to learn more about how Biotech Booster, RegMed XB and Oncode Accelerator collaborate and what we offer to support projects.
